Theravance Biopharma, Inc. (TBPH)

Theravance Biopharma, Inc. (TBPH) Q3 2022 Earnings Call Transcript
Nov. 8, 2022 | Source: Seeking Alpha

Theravance Biopharma, Inc.'s (TBPH) CEO Rick Winningham on Q2 2022 Results - Earnings Call Transcri
Aug. 7, 2022 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q1 2022 Results -Earnings Call Transcript
May 7, 2022 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q4 2021 Results - Earnings Call Transcript
Feb. 24, 2022 | Source: Seeking Alpha

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q3 2021 Results - Earnings Call Transcript
Nov. 4, 2021 | Source: Seeking Alpha

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q2 2021 Results - Earnings Call Transcript
Aug. 4, 2021 | Source: Seeking Alpha

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q1 2021 Results - Earnings Call Transcript
May 5, 2021 | Source: Seeking Alpha

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q4 2020 Results - Earnings Call Transcript
Feb. 24, 2021 | Source: Seeking Alpha

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q3 2020 Results - Earnings Call Transcript
Nov. 8, 2020 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q2 2020 Results - Earnings Call Transcript
Aug. 8, 2020 | Source: Seeking Alpha

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q1 2020 Results - Earnings Call Transcript
May 7, 2020 | Source: Seeking Alpha

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q4 2019 Results - Earnings Call Transcript
Feb. 25, 2020 | Source: Seeking Alpha

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q3 2019 - Earnings Call Transcript
Nov. 9, 2019 | Source: Seeking Alpha

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q2 2019 Results - Earnings Call Transcript
Aug. 1, 2019 | Source: Seeking Alpha

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q1 2019 Results - Earnings Call Transcript
May 7, 2019 | Source: Seeking Alpha

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q4 2018 Results - Earnings Call Transcript
Feb. 26, 2019 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q4 2017 Results - Earnings Call Transcript
Feb. 27, 2018 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q3 2017 Results - Earnings Call Transcript
Nov. 7, 2017 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q2 2017 Results - Earnings Call Transcript
Aug. 12, 2017 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q1 2017 Results - Earnings Call Transcript
May 9, 2017 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q4 2016 Results - Earnings Call Transcript
Feb. 28, 2017 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q1 2016 Results - Earnings Call Transcript
Nov. 8, 2016 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q2 2016 Results - Earnings Call Transcript
Aug. 8, 2016 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q1 2016 Results - Earnings Call Transcript
May 9, 2016 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q4 2015 Results - Earnings Call Transcript
March 9, 2016 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q3 2015 Results - Earnings Call Transcript
Nov. 10, 2015 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q2 2015 Results - Earnings Call Transcript
Aug. 10, 2015 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q1 2015 Results - Earnings Call Transcript
May 7, 2015 | Source: Seeking Alpha

Theravance Biopharma's (TBPH) CEO Rick Winningham on Q4 2014 Results - Earnings Call Transcript
March 10, 2015 | Source: Seeking Alpha

Theravance's (TBPH) CEO Rick Winningham on Q3 2014 Results - Earnings Call Transcript
Nov. 7, 2014 | Source: Seeking Alpha

Recent filings

Theravance Biopharma, Inc. insider just disposed of 2,084 shares - Dec. 5, 2022

Theravance Biopharma, Inc. insider just disposed of 10,000 shares - Nov. 23, 2022

Theravance Biopharma, Inc. insider just disposed of 15,804 shares - Nov. 22, 2022

Theravance Biopharma, Inc. insider just disposed of 90,057 shares - Nov. 22, 2022

Theravance Biopharma, Inc. insider just disposed of 23,268 shares - Nov. 22, 2022

Tender offer statement by Issuer - Nov. 22, 2022

Theravance Biopharma, Inc. insider just disposed of 27,350 shares - Nov. 22, 2022

Tender offer statement by Issuer - Nov. 18, 2022

Theravance Biopharma, Inc. insider just disposed of 2,800 shares - Nov. 17, 2022

Tender offer statement by Issuer - Nov. 14, 2022

Theravance Biopharma: Unaudited Pro Forma Condensed Consolidated Financial Statements - Nov. 14, 2022

Tender offer statement by Issuer - Nov. 9, 2022

Theravance Biopharma, Inc. Just Filed Its Quarterly Report: 2. Net Income (Loss)... - Nov. 9, 2022

Tender offer statement by Issuer - Nov. 7, 2022

Current report, items 2.02 and 9.01 - Nov. 7, 2022

Current report, items 7.01 and 9.01 - Nov. 3, 2022

Major owner of Theravance Biopharma, Inc. just declared owning 7,012,226 shares of Theravance Biopharma, Inc. - Oct. 21, 2022

Major owner of Theravance Biopharma, Inc. just declared owning 7,457,060 shares of Theravance Biopharma, Inc. - Sept. 28, 2022

Tender offer statement by Issuer - Sept. 28, 2022

GSK plc just issued a filing suggesting it has sold all of its Theravance Biopharma, Inc. - Sept. 20, 2022

Theravance Biopharma, Inc. insider just disposed of 9,644,807 shares - Sept. 20, 2022

As previously reported on the Current Report on Form  - Sept. 20, 2022

Written communication relating to an issuer or third party - Sept. 19, 2022

Entry into a Material Definitive - Sept. 19, 2022

Current report, items 7.01 and 9.01 - Sept. 13, 2022

As previously - Aug. 25, 2022

Tender offer statement by Issuer - Aug. 25, 2022

Theravance Biopharma, Inc. insider just disposed of 10,413 shares - Aug. 23, 2022

Theravance Biopharma, Inc. insider just disposed of 25,676 shares - Aug. 23, 2022

Theravance Biopharma, Inc. insider just disposed of 18,991 shares - Aug. 23, 2022

Theravance Biopharma, Inc. insider just disposed of 15,804 shares - Aug. 23, 2022

Theravance Biopharma, Inc. insider just disposed of 4,906 shares - Aug. 18, 2022

Theravance Biopharma, Inc. insider just disposed of 15,086 shares - Aug. 11, 2022

Tender offer statement by Issuer - Aug. 8, 2022

Theravance Biopharma, Inc. Just Filed Its Quarterly Report: 2. Net Loss per Shar... - Aug. 8, 2022

Tender offer statement by Issuer - Aug. 5, 2022

Theravance Biopharma, Inc. Reports Second Quarter 2022 Financial Results - Aug. 4, 2022

General statement of acquisition of beneficial ownership - Aug. 3, 2022

Theravance Biopharma, Inc. insider just picked up 20,000 shares - July 27, 2022

Tender offer statement by Issuer - July 26, 2022

Completion of Acquisition or Disposition of - July 20, 2022

Written communication relating to an issuer or third party - July 14, 2022

Entry into a Material Definitive - July 14, 2022

Written communication relating to an issuer or third party - July 13, 2022

Theravance Biopharma To Sell Trelegy Ellipta Royalty Interests To Royalty Pharma For Approximately $1.1 Billion In Upfront Cash With Over $1.5 Billion In Potential Total Value - July 13, 2022

WEISS ASSET MANAGEMENT LP just provided an update on share ownership of Theravance Biopharma, Inc. - June 16, 2022

Theravance Biopharma, Inc. insider just disposed of 3,947 shares - May 24, 2022

Theravance Biopharma, Inc. insider just disposed of 11,025 shares - May 24, 2022

Theravance Biopharma, Inc. insider just disposed of 3,365 shares - May 24, 2022

Theravance Biopharma, Inc. insider just disposed of 3,281 shares - May 24, 2022

Theravance Biopharma, Inc. Just Filed Its Quarterly Report: 2. Net Loss per Shar... - May 6, 2022

Theravance Biopharma, Inc. insider just picked up 9,852 shares - April 28, 2022

Theravance Biopharma, Inc. insider just picked up 9,852 shares - April 28, 2022

Theravance Biopharma, Inc. insider just picked up 9,852 shares - April 28, 2022

Theravance Biopharma, Inc. insider just picked up 9,852 shares - April 28, 2022

Theravance Biopharma, Inc. insider just picked up 9,852 shares - April 28, 2022

Theravance Biopharma, Inc. insider just picked up 9,852 shares - April 28, 2022

Theravance Biopharma, Inc. insider just picked up 9,852 shares - April 28, 2022

Submission of Matters to a Vote of Security - April 28, 2022

Theravance Biopharma, Inc. Announces Results From Study 0170, A Second Phase 3 Study Of Ampreloxetine, In Patients With Symptomatic Neurogenic Orthostatic Hypotension (Noh) - April 4, 2022

Theravance Biopharma, Inc. releases salary data. CEO sees compensation fall -32% - March 25, 2022

Securities to be offered to employees in employee benefit plans - March 4, 2022

Theravance Biopharma, Inc. insider just disposed of 2,356 shares - March 2, 2022

Theravance Biopharma, Inc. insider just picked up 170,000 shares - March 1, 2022

Theravance Biopharma, Inc. insider just disposed of 22,710 shares - Feb. 23, 2022

Theravance Biopharma, Inc. insider just disposed of 20,377 shares - Feb. 23, 2022

Theravance Biopharma, Inc. insider just disposed of 25,973 shares - Feb. 23, 2022

Theravance Biopharma, Inc. insider just disposed of 11,824 shares - Feb. 23, 2022

Theravance Biopharma, Inc. insider just disposed of 8,369 shares - Feb. 23, 2022

Theravance Biopharma, Inc. insider just disposed of 27,299 shares - Feb. 23, 2022

Theravance Biopharma, Inc. Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Business Update - Feb. 23, 2022

Eli Samaha just provided an update on share ownership of Theravance Biopharma, Inc. - Feb. 14, 2022

OrbiMed Advisors LLC just provided an update on share ownership of Theravance Biopharma, Inc. - Feb. 11, 2022

The Vanguard Group just provided an update on share ownership of Theravance Biopharma, Inc. - Feb. 10, 2022

General statement of acquisition of beneficial ownership - Feb. 10, 2022

Theravance Biopharma, Inc. insider just picked up 52,000 shares - Feb. 9, 2022

BlackRock, Inc. just provided an update on share ownership of Theravance Biopharma, Inc. - Feb. 3, 2022

Theravance Biopharma: Copd And Asthma Background - Jan. 10, 2022

Termination of a Material Definitive - Dec. 22, 2021

SVP of Theravance Biopharma, Inc. just picked up 27,500 shares - Dec. 16, 2021

The information in this Current Report is being furnished and shall not be deemed - Dec. 16, 2021

SVP of Theravance Biopharma, Inc. just declared owning 319,951 shares of Theravance Biopharma, Inc. - Dec. 10, 2021

SVP of Theravance Biopharma, Inc. just picked up 240,000 shares - Dec. 6, 2021

Departure of Directors or Certain - Dec. 6, 2021

SVP of Theravance Biopharma, Inc. just picked up 340,000 shares - Dec. 6, 2021

Theravance Biopharma, Inc. insider just disposed of 4,310 shares - Nov. 23, 2021

Theravance Biopharma, Inc. insider just disposed of 3,779 shares - Nov. 23, 2021

Theravance Biopharma, Inc. insider just disposed of 4,263 shares - Nov. 23, 2021

Theravance Biopharma, Inc. insider just disposed of 1,350 shares - Nov. 23, 2021

Theravance Biopharma, Inc. insider just disposed of 5,191 shares - Nov. 23, 2021

Theravance Biopharma, Inc. insider just disposed of 4,310 shares - Nov. 23, 2021

Theravance Biopharma, Inc. insider just disposed of 11,404 shares - Nov. 23, 2021

Theravance Biopharma, Inc. insider just disposed of 3,169 shares - Nov. 23, 2021

The information in this Current Report is being furnished and shall not be deemed - Nov. 16, 2021

Theravance Biopharma, Inc. Just Filed Its Quarterly Report: 2. Net Loss per Shar... - Nov. 8, 2021

Theravance Biopharma, Inc. Reports Third Quarter 2021 Financial Results And Provides Business Update - Nov. 3, 2021

Statement of acquisition of beneficial ownership by individuals - Oct. 12, 2021

Wellington Investment Advisors Holdings LLP just provided an update on share ownership of Theravance Biopharma, Inc. - Oct. 8, 2021

Effective September 30, 2021 (The “Effective Date”), Bradford J. Shafer (“Consultant”) And Theravance Biopharma Us, Inc. (“Theravance Biopharma” Or The “Company”) Agree As Follows - Oct. 5, 2021

Eli Samaha just provided an update on share ownership of Theravance Biopharma, Inc. - Sept. 27, 2021

Sorry, no schedule available for this company

Theravance Biopharma, Inc. Announces Final Results of Tender Offer - Nov. 22, 2022

Theravance Biopharma, Inc. Announces Preliminary Results of Tender Offer - Nov. 18, 2022

Theravance Biopharma, Inc. (TBPH) Q3 2022 Earnings Call Transcript - Nov. 8, 2022

Theravance Biopharma to Report Third Quarter 2022 Financial Results on November 7, 2022 - Oct. 31, 2022

Theravance Biopharma Announces Tender Offer For Up To $95 Million Of Its Ordinary Shares - Sept. 28, 2022

Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update - Feb. 23, 2022

Theravance Biopharma to Participate in an Upcoming Investor Conference - Feb. 22, 2022

Theravance Biopharma to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022 - Feb. 9, 2022

Theravance Biopharma to Participate in an Upcoming Investor Conference - Feb. 2, 2022

Theravance Biopharma to Present at the 40th Annual J.P. Morgan Healthcare Conference - Jan. 5, 2022

Theravance Biopharma to Report Third Quarter 2021 Financial Results November 3, 2021 - Oct. 20, 2021

Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio - Sept. 15, 2021

Theravance Biopharma to Report Second Quarter 2021 Financial Results on August 3, 2021 - July 20, 2021

Theravance Biopharma, Inc. Announces Proposed Public Offering of Ordinary Shares - June 24, 2021

Theravance Biopharma, Inc. Announces Pricing of Public Offering of Ordinary Shares - June 24, 2021

Theravance Biopharma, Inc. Reports First Quarter 2021 Financial Results and Provides Business Update - May 4, 2021

Theravance Biopharma to Report First Quarter 2021 Financial Results on May 4, 2021 - April 20, 2021

Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update - Feb. 23, 2021

Theravance Biopharma to Participate in Upcoming Investor Conferences - Feb. 10, 2021

Theravance Biopharma to Report Fourth Quarter and Full Year 2020 Financial Results on February 23, 2021 - Feb. 9, 2021

 


Feedback